Centers for Disease Control and Prevention (CDC) — 2022 Investments
11 investments dated 2022 · listed companies and verified rows first · show all
Adámas Nanotechnologies manufactures nanodiamond materials and instrumentation, including NV diamond particles and plates, ODMR systems, and detonation nanodiamond powders and slurries.
Deep TechNew MaterialsQuantum Computing
AEMS Corp solves viscosity problems in liquid formulations using proprietary and patented methods and an automated high-throughput, microscale lab, focusing primarily on next-generation pharmaceuticals such as high-concentration injectable biologics and siRNA therapeutics.
BiotechDeep TechNew MaterialsDenver, US
William Compel(Executive Officer, Director)Nicholas Collella(Director)W. Scott Compel(Chief Executive Officer & Co-Founder)Alexander R. Hendricks(Chief Innovation Officer & Co-Founder)Nick Colella(Co-Founder)
BoardMichael Chang(Director)
Nanohmics develops a chip-scale snapshot hyperspectral image sensor that integrates into standard COTS imaging systems with minimal size, weight, and power impact.
Deep TechHardwareSemiconductors
An online store selling piezoelectric PVDF films, sensors, copolymer resins, and high-voltage piezo driver amplifiers for applications such as energy harvesting, elongation sensing, and ultrasound fingerprint sensing.
E-commerceHardwareNew Materials
Saavsus Inc. develops and publishes evidence-based educational and health-behavior programs—such as bilingual oral-health handouts, parenting curricula, physical-education programs, and job-readiness lessons—for clinicians, educators, and community partners.
EdTechHealthtechImpact & Social Good
Vectech develops AI-powered vector identification and surveillance technologies to support public health interventions and targeted mosquito control during disease outbreaks.
AI & Machine LearningBiotechData & InfrastructureGovTechHealthtechBaltimore, US
Tristan Ford(Co-founder + CEO)Meg Glancey(Co-founder + Advisor)Autumn Goodwin(Co-founder + Chief Technology Officer)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.